Alterations in peripheral myelin protein 22 (PMP22) gene expression are associated with demyelinating peripheral neuropathies. Overexpression of wild type (wt) PMP22 or inhibition of proteasomal degradation lead to the formation of aggresomes, intracellular ubiquitinated PMP22 aggregates. Aggresome formation has now been observed with two mutant PMP22s, the Tr-and TrJ-PMP22 when the proteasome is inhibited. The formation of these aggresomes required intact microtubules and involved the recruitment of chaperones, including Hsp40, Hsp70, and ␣B-crystallin. Spontaneously formed ubiquitinated PMP22 aggregates were also observed in Schwann cells of homozygous TrJ mice. Significant upregulation of both the ubiquitin-proteasomal and lysosomal pathways occurred in affected nerves suggesting that two pathways of PMP22 degradation are present. Thus, the presence of aggresomes appears to be a common finding in neuropathy models of PMP22 overexpression and of some point mutations known to cause neuropathy in mice and humans. © 2002 Elsevier Science (USA)
INTRODUCTION
Peripheral myelin protein 22 (PMP22) is a hydrophobic, tetraspan glycoprotein expressed mainly in Schwann cells (SCs) and found in compact peripheral myelin (Snipes et al., 1992) . Duplication of the PMP22 gene is responsible for the majority of cases of the heritable peripheral neuropathy, Charcot-Marie-Tooth 1A (CMT1A) disease, while mutations in PMP22 underlie a more severe form of CMT1A and DejerineSottas disease (Naef and Suter, 1998; Lupski and Garcia, 2001) . Two well-known PMP22 mutations occur in the Trembler (Tr) and Trembler-J (TrJ) mice (Suter et al., 1992a (Suter et al., , 1992b and both of these mutations are found in humans.
Both endogenous and transiently transfected wtPMP22s are rapidly degraded in cultured rat SCs and in ex vivo nerve explants (Pareek et al., 1997; Ryan et al., 2000) . A small fraction of PMP22 traverses the Golgi, acquires a complex N-linked sugar moiety, and trafficks to the SC membrane. This high turnover rate of newly synthesized PMP22 is likely due to misfolding of the protein or incorrect insertion in the membrane, a feature common to many proteins (Sanders and Nagy, 2000; Sanders et al., 2001) . Misfolded proteins are subject to the quality control mechanism in the endoplasmic reticulum (ER), or Golgi, and they can be refolded in the ER or degraded in the cytosol by the ubiquitin-proteasome pathway (Ellgaard et al., 1999) . The rapidly degraded wt-PMP22 is endoglycosidase H (endo H) sensitive, suggesting that it is degraded from the ER (Pareek et al., 1997) .
When the degradation capacity of the cell is overwhelmed by overexpression of misfolded proteins and/or inhibition of the proteasome, intracellular aggregates or aggresomes form (Johnston et al., 1998; Garcia-Mata et al., 1999; Notterpek et al., 1999; Kopito, 2000) . Aggresome formation requires intact microtubules and results in the redistribution of vimentin (Johnston et al., 1998; Notterpek et al., 1999; Kopito, 2000) .
The trafficking of both Tr-and TrJ-PMP22 in Schwann and other cells differs from that of wt-PMP22. Tr-PMP22 is mainly retained in the ER (Naef 
